|
Mold Troubles at Sanofi Pasteur’s Toronto Plant Prompt Shutdown
Sanofi Pasteur has suspended production at its Toronto, Canada, plant to address mold troubles that recently landed the drugmaker an FDA Form 483 and prompted global shortages of a tuberculosis (TB) vaccine and a bladder cancer treatment produced there, the company says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives